Genetic Tech Spn ADR (GENE)

Oct 11, 2024, 9:00 AM EDT - 8 months ago

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

BIVI

Sep 23, 2024, 8:30 AM EDT - 9 months ago

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2

Sep 11, 2024, 8:15 AM EDT - 9 months ago

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

Jul 26, 2024, 8:00 AM EDT - 11 months ago

Genetic Technologies Strategic Restructure Driving USA Sales Growth

Jul 16, 2024, 8:00 AM EDT - 11 months ago

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

Jun 25, 2024, 8:00 AM EDT - 1 year ago

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Jun 21, 2024, 8:00 AM EDT - 1 year ago

Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Appendix 4C & Quarterly Business Update – March 2024

Apr 22, 2024, 3:00 PM EDT - 1 year ago

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

Apr 18, 2024, 12:17 PM EDT - 1 year ago

Genetic Technologies Announces $2 Million Registered Direct Offering

Apr 12, 2024, 9:00 AM EDT - 1 year ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

BIVI

Apr 2, 2024, 8:05 AM EDT - 1 year ago

Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

Feb 28, 2024, 8:00 AM EST - 1 year ago

GTG to launch U.S. Customer Digital Media Sales Campaign

Jan 5, 2024, 8:00 AM EST - 1 year ago

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Dec 29, 2023, 9:00 AM EST - 1 year ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

BIVI

Dec 12, 2023, 8:00 AM EST - 1 year ago

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

Oct 18, 2023, 8:30 AM EDT - 1 year ago

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

Oct 6, 2023, 9:00 AM EDT - 1 year ago

Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

KSCP SNGX

Sep 27, 2023, 9:00 AM EDT - 1 year ago

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

Sep 15, 2023, 9:00 AM EDT - 1 year ago

Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

AREC

Sep 11, 2023, 8:30 AM EDT - 1 year ago

GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

Sep 1, 2023, 10:00 AM EDT - 1 year ago

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

Sep 1, 2023, 9:00 AM EDT - 1 year ago

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

SXTP

Aug 30, 2023, 8:45 AM EDT - 1 year ago

Annual Results – Momentum Building on our Commercial Plans

Aug 18, 2023, 8:30 AM EDT - 1 year ago

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

CDIO

Aug 9, 2023, 12:11 AM EDT - 1 year ago

Genetic Technologies Limited (GENE) Q4 2023 Earnings Call Transcript

Jul 21, 2023, 8:00 AM EDT - 2 years ago

Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

May 3, 2023, 11:45 PM EDT - 2 years ago

Genetic Technologies Limited (GENE) Q3 2023 Earnings Call Transcript

Apr 28, 2023, 8:00 AM EDT - 2 years ago

New Publication Validates geneType for Melanoma Risk Assessment

Mar 13, 2023, 8:00 AM EDT - 2 years ago

Back-to-back Studies Validate geneType Breast Cancer Risk Test

Feb 27, 2023, 7:56 PM EST - 2 years ago

Genetic Technologies Limited (GENE) Q2 2023 Earnings Call Transcript

Feb 7, 2023, 10:00 AM EST - 2 years ago

Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

Feb 6, 2023, 8:00 AM EST - 2 years ago

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

Feb 3, 2023, 8:35 AM EST - 2 years ago

Genetic Technologies Announces $5 Million Registered Direct Offering

Feb 3, 2023, 8:00 AM EST - 2 years ago

GENE to Launch World's First Comprehensive Risk Test for Breast & Ovarian Cancer

Jan 30, 2023, 8:00 AM EST - 2 years ago

Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth

Dec 6, 2022, 8:00 AM EST - 2 years ago

GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes

Nov 6, 2022, 6:59 AM EST - 2 years ago

Genetic Technologies Limited (GENE) Q1 2023 Earnings Call Transcript

Oct 25, 2022, 9:14 AM EDT - 2 years ago

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

Oct 13, 2022, 8:00 AM EDT - 2 years ago

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Sep 29, 2022, 8:00 AM EDT - 2 years ago

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Sep 2, 2022, 8:00 AM EDT - 2 years ago

Genetic Technologies Provides Update on US Operations and Payer Engagement

Aug 30, 2022, 8:00 AM EDT - 2 years ago

GENE Momentum building - a year in review

Jul 28, 2022, 8:00 AM EDT - 3 years ago

Gene achieves key milestones and growth

Jul 14, 2022, 8:00 AM EDT - 3 years ago

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

Jul 1, 2022, 8:00 AM EDT - 3 years ago

GeneType Risk Assessment Test onboarding in 16 clinics

May 16, 2022, 9:00 AM EDT - 3 years ago

Acquisition of global direct to consumer ecommerce business

Apr 20, 2022, 10:54 PM EDT - 3 years ago

Genetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results - Earnings Call Transcript

Apr 8, 2022, 8:00 AM EDT - 3 years ago

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

Feb 14, 2022, 1:01 PM EST - 3 years ago

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2022 Results - Earnings Call Transcript